Please login to the form below
Avonex
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.
Absorb the impact
Therapeutic area. How it works. Comments. Performance-based schemes. Betaferon (Schering), Avonex (Biogen), Rebif (Merck Serono), Copaxone (Teva/Aventis).
MS treatment hopes
Clinicians may recommend one of three interferons (Biogen Idec's Avonex or EMD Serono/Pfizer's Rebif, which are both formulations of interferon ß-1a, or Bayer's Betaseron, an interferon ... which will both assess relapse rates, and TRANSFORMS (in
The PM Society Advertising Awards 2008
London. Highly commended: Avonex by Seven Stones for Biogen Idec. Winner: Duac. ... AstraZeneca. Highly commended: Avonex by Seven Stones for Biogen Idec. Winner: Gout Awareness.
Pharma news in brief
15, 500) per patient a year. Tysabri was withdrawn from the market at the beginning of 2005, after two patients taking it in combination with another Biogen MS drug, Avonex, developed
Pharma news in brief
combined with Avonex developed fatal brain conditions, its shares took another nose dive on reports in the Boston Globe newspaper that another patient (on monotherapy) had contracted a deadly disease.
[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- ONS data reveals significant decrease in COVID-19 antibodies
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Eli Lilly to make bebtelovimab commercially available to US states from August
- ONS records a continued fall in UK COVID-19 infections
- Moderna’s Omicron booster receives MHRA approval
- Lack of evidence for AstraZeneca’s COVID-19 vaccine says UK Department of Health
- NHS England outlines measures to boost capacity ahead of substantial winter pressures
- New research shows drug candidate may effectively treat antibiotic-resistant bacteria
- Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
- Engaging KOLs and Gaining Insights in Pharma's New Normal
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Roche shares new positive Ocrevus data for MS patients
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- bluebird bio reveals plans to launch two gene therapies
- NHS App to revolutionise digital health and care with major digital updates by 2023
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
- How the Royal Society’s EiR programme can help to drive UK innovation
- ...
